ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1,4,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1,6,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1,7,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,8,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1,9,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,12,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,13,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1,14,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,16,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,17,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1,18,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,19,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1,20,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1,21,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1,22,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1,23,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1,24,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1,25,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,26,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1,27,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1,28,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3,5,Faecal vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,10,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3,11,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,Y
3,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
5,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
6,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
6,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
7,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
8,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
8,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
8,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
8,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
10,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
10,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
11,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
12,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
12,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
13,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
13,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
14,1,Abdominal operation,Abdominal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
14,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
15,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
16,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
16,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
16,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
16,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
16,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
16,6,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
16,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
16,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
16,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
17,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
17,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
17,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
17,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
18,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
19,1,Carbohydrate antigen 125 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
19,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
20,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
20,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
21,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
21,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
21,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
21,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
21,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
21,7,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
22,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
22,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
24,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
24,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
25,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
25,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
26,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
26,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
26,3,Haematology test abnormal,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
27,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
27,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
28,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
29,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
29,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
31,1,Ovarian cancer metastatic,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
32,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
33,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
34,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
35,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
35,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
35,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
36,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
37,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
38,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
38,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
38,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
38,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
39,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
40,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
42,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
42,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
42,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
43,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
43,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
43,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,7,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
43,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
43,9,Excessive eye blinking,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
43,10,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
43,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
43,12,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
43,13,Mean cell volume abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
43,14,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
43,15,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
43,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,17,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
43,18,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
43,19,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,20,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
43,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
44,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
45,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
46,1,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
46,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
47,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
47,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
47,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
47,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
47,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
47,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
47,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
47,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
48,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
48,3,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
48,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
48,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
48,6,Platelet toxicity,Platelet disorders NEC,Platelet disorders,Blood,N
49,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
49,2,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
49,3,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
49,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
49,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
50,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
50,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
51,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
51,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
52,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
53,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
53,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
53,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
53,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
54,1,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
55,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
56,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
56,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
57,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
57,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
58,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
58,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
59,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
59,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
59,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
59,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
59,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
59,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
59,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
59,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,10,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
59,11,Headache,Headaches NEC,Headaches,Nerv,N
59,12,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
59,13,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
59,14,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
59,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,16,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
59,17,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
59,18,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
59,19,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,20,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
59,21,Throat lesion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
59,22,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
59,23,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
60,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
60,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
60,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
60,4,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
60,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
61,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
61,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
61,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
61,4,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
61,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
61,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
62,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
62,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
62,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
62,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
62,6,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
63,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
63,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
64,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
65,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
65,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
66,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
66,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
66,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
67,1,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
67,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
68,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
69,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
70,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
70,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
70,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
71,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
71,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
72,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
73,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
73,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
73,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
74,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
75,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
76,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
76,2,Anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
77,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
78,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
79,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
80,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
80,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
80,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
81,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
81,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
83,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
83,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
83,3,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
84,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
84,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
86,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
87,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
88,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
89,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
90,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
91,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
92,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
92,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
92,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
92,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
93,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
93,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
94,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
96,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
97,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
98,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
99,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
99,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
100,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
101,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
102,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
102,3,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
102,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
102,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
102,6,Platelet toxicity,Platelet disorders NEC,Platelet disorders,Blood,N
103,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
104,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
105,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
105,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
105,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
105,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
106,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
106,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
106,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
106,4,Headache,Headaches NEC,Headaches,Nerv,N
106,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
106,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
106,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
107,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
107,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
108,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
108,2,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
108,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
108,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
108,5,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
108,6,Headache,Headaches NEC,Headaches,Nerv,N
108,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
108,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
108,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
108,10,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
108,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
109,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
110,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
110,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
111,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
111,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
111,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
112,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
112,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
113,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
113,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
115,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,2,Carbohydrate antigen 125 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
116,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
117,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
118,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
119,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
119,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
119,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
120,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
121,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
122,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
122,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
123,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
124,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
125,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
125,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
126,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
126,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
127,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
129,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
130,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
130,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
132,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
133,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
134,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
134,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
135,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
135,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
135,3,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
135,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
135,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
136,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
136,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
137,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
137,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
138,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
138,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
139,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
140,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
140,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
140,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
141,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
141,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
142,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
143,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
144,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
144,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
145,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
